As used in this part:
- (1) “Control officer” means State Tuberculosis Control Officer;
- (2) “Department” means Department of Health;
- (3) “Division” means Division of Tuberculosis, Department of Health;
- (4) “Radiograph” means standard fourteen-inch by seventeen-inch (14” x 17”) antero-posterior seventy-two-inch (72”) chest radiograph;
(5)
(A) “Student” means any person:
- (i) Born in a country where TB is endemic;
- (ii) Who is not a permanent resident; and
- (iii) Who receives instruction in a room in which other students are present.
- (B) People who receive only individual instruction at which only they and an instructor are present are excluded.
- (C) People who receive instruction solely by electronic means are excluded if no other students occupy the room in which they receive instruction at the same time.
- (D) Part-time students as well as full-time students are included.
- (E) Auditors are included.
- (F) TB is not endemic in the countries listed below, and students from these countries are not included: American Region: Canada Saint Lucia Jamaica USA Saint Kitts and Nevis Virgin Islands (USA) European Region: Belgium Luxembourg Denmark Malta Finland Monaco France Netherlands Germany Norway Greece San Marino Iceland Sweden Ireland Switzerland Italy United Kingdom Liechtenstein Western Pacific Region: American Samoa Australia New Zealand; and
(6) “Tuberculin tests” means:
- (A) Tuberculin skin test (TST) performed by the Mantoux method, consisting of intradermal injection of five tuberculin units (5TU) of purified protein derivative (PPD) in a volume of one-tenth of one milliliter (0.1 ml), read in forty-eight (48) to seventy-two (72) hours by measuring the palpable induration, with a positive reaction being ten millimeters (10 mm) or greater in diameter; or
- (B) Special TB blood tests (interferon-gamma release assays (IGRAs)) to measure how the immune system reacts to the bacteria that cause TB.
Codification Notes: "TB" means tuberculosis.